Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Current Liabilities (2016 - 2025)

Collegium Pharmaceutical has reported Total Current Liabilities over the past 10 years, most recently at $440.0 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $440.0 million for Q4 2025, down 13.64% from a year ago — trailing twelve months through Dec 2025 was $440.0 million (down 13.64% YoY), and the annual figure for FY2025 was $440.0 million, down 13.64%.
  • Total Current Liabilities for Q4 2025 was $440.0 million at Collegium Pharmaceutical, down from $452.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for COLL hit a ceiling of $509.5 million in Q4 2024 and a floor of $226.8 million in Q2 2021.
  • Median Total Current Liabilities over the past 5 years was $437.5 million (2023), compared with a mean of $406.7 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 82.99% in 2022 and later decreased 13.64% in 2025.
  • Collegium Pharmaceutical's Total Current Liabilities stood at $279.6 million in 2021, then soared by 55.14% to $433.7 million in 2022, then increased by 5.58% to $457.9 million in 2023, then grew by 11.27% to $509.5 million in 2024, then decreased by 13.64% to $440.0 million in 2025.
  • The last three reported values for Total Current Liabilities were $440.0 million (Q4 2025), $452.9 million (Q3 2025), and $464.6 million (Q2 2025) per Business Quant data.